Hydrogels are a unique group of biocompatible 3D polymeric substances which can act as a scaffold and mimic the properties of various tissues in the body. The mechanism is by incorporating cells in their structure while eventually degrading themselves to leave behind only healthy tissue
This report contains market size and forecasts of Hydrogels for Tissue Engineering in global, including the following market information:
Global Hydrogels for Tissue Engineering Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hydrogels for Tissue Engineering Market Sales, 2017-2022, 2023-2028, (K Tons)
Global top five Hydrogels for Tissue Engineering companies in 2021 (%)
The global Hydrogels for Tissue Engineering market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Natural Hydrogels Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hydrogels for Tissue Engineering include Teikoku Pharma, Hisamitsu, Johnson & Johnson, Novartis, ConvaTec, Smith&Nephew United, Hollister, Paul Hartmann and Coloplast, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hydrogels for Tissue Engineering manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hydrogels for Tissue Engineering Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Hydrogels for Tissue Engineering Market Segment Percentages, by Type, 2021 (%)
Natural Hydrogels
Synthetic Hydrogels
Global Hydrogels for Tissue Engineering Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Hydrogels for Tissue Engineering Market Segment Percentages, by Application, 2021 (%)
Drug Delivery Systems (DDS)
Hydrogel Dressings
Implants
Others
Global Hydrogels for Tissue Engineering Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Hydrogels for Tissue Engineering Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hydrogels for Tissue Engineering revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hydrogels for Tissue Engineering revenues share in global market, 2021 (%)
Key companies Hydrogels for Tissue Engineering sales in global market, 2017-2022 (Estimated), (K Tons)
Key companies Hydrogels for Tissue Engineering sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teikoku Pharma
Hisamitsu
Johnson & Johnson
Novartis
ConvaTec
Smith&Nephew United
Hollister
Paul Hartmann
Coloplast
3M
Molnlycke Health Care
Axelgaard
Guojia